Immunogenicity Study of the Covid-19 (Recombinante) Vaccine With a 4 or 8 Week Interval Between the First Doses.
Clinical trial NCT05157178 · UNKNOWN
Trial details
- NCT number
- NCT05157178
- Sponsor
- The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-20
- Primary completion
- 2022-03-31
- Enrollment
- 1264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.